Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 5 Insider Annual Insider Trading Report
  6. 4 Open-market sale President and CEO sold 21,353 shares at $8.96 ($191,323)
  7. 4 Open-market sale SVP, CFO, Sec & Treasurer sold 9,564 shares at $8.96 ($85,693)
  8. 4 Open-market sale SVP & Chief Medical Officer sold 12,380 shares at $8.96 ($110,925)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy 10% owner bought 11,170 shares at $8.97 ($100,156)
  12. 4/A Open-market buy 10% owner bought 425,982 shares at an average $8.60 ($3,665,308)
  13. 4 Open-market buy 10% owner bought 1,201,364 shares at an average $8.38 ($10,063,274)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale President and CEO sold 131,739 shares at an average $12.68 ($1,670,486)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 13 of 29 · 579 filings